A new animal study out of the Washington University School of Medicine indicates that disruptions in an individual’s sleep-wake cycle may be an early indicator of Alzheimer’s disease.
Scientists measured amyloid plaques, one of the defining brain abnormalities associated with Alzheimer’s disease, in mice that were genetically altered to develop these Alzheimer’s plaques as they age. Researchers found that when the first indicators of these plaques began to appear, mice began experiencing a change in their sleep patterns. Mice generally sleep 40 minutes during every hour of daylight, but when the plaques began forming the mice averaged just 30 minutes of sleep during every hour of daylight. In aging mice that did not develop Alzheimer’s plaques, no change in sleep patterns was observed.
“If sleep abnormalities begin this early in the course of human Alzheimer’s disease, those changes could provide us with an easily detectable sign of pathology,” says senior author David M. Holtzman, MD, the Andrew B. and Gretchen P. Jones Professor and head of Washington University’s Department of Neurology. “As we start to treat Alzheimer’s patients before the onset of dementia, the presence or absence of sleep problems may be a rapid indicator of whether the new treatments are succeeding.”
More research will be needed to establish a cause and effect relationship or prove this correlation in humans, but previous studies have found that amyloid levels and plaques behave similarly in both humans and mice.
Read more about the Alzheimer's disease study, including an audio overview of the findings.
The National Institutes of Health recently released recommendations providing a framework for an Alzheimer’s disease research agenda that was develope...
End of Life, Federal Agency Activity, Managed Risk, Medication Management, Memory Care Best Practices and Research
Federal and state policies generally encourage the use of available generic drug products as do private payers such as insurers and others, which is w...
The National Institutes of Health is encouraging people to volunteer for clinical trials that look for ways to prevent, slow and treat Alzheimer’s dis...
Formalizing standards around memory care is the top priority for the newly formed ALFA Memory Care Roundtable. The group, which met in person for the ...
Cognitive aging is a natural process associated with advancing years and the Institute of Medicine recently released a report assessing the public hea...
Memory Care Best Practices and Research, Memory Care Education
The National Institute on Aging has created a new online portal offering free clinical practice tools, training materials, and other resources for hea...
Health and Wellness, Hearings, Managed Risk, Medication Management, Memory Care Best Practices and Research, Memory Care Education
Two senators last week sent a letter seeking more information from the Health and Human Services Department on its efforts to address the improper pre...
End of Life, Facts and Figures, Memory Care Best Practices and Research, Memory Care Education, Reports
The Alzheimer’s Association has released its 2015 Alzheimer’s Disease facts and figures report including startling statistics such as one in three sen...
Disabilities, End of Life, Memory Care Best Practices and Research, Memory Care Education, Risk Management
Standards body CARF International has revised its standards for dementia specialty programs, available in the 2015 editions of the CARF-CCAC and Aging...
End of Life, Memory Care Best Practices and Research, Partnerships
The National Institutes of Health and partner groups have embarked on a new data portal to speed Alzheimer’s disease drug discovery.